Financial Info

Button Selector
Quarterly Release
Annual Reports
Subsidiary Accounts
Q1
Q2
Q3
Q4

H1Q2_2026_Financial Results & RPT Disclosure

H1Q2_FY2026_Concall_Transcript

Q1_FY2026_Concall_Transcript

Q1FY2026_Concall_Audio

Q1_FY26_Financial Results

Q1_Schedule of Conference Call for Investors on August 13, 2025

Q4_2025_Financial Results & RPT Disclosure

FY2025 - Concall Transcript

FY2025_Concall_Audio

Financial Results 2024-25

Q4_Schedule of Conference Call for Investors on May 28, 2025

Schedule of B&K, Macquarie Roadshow on March 31, April 1, 2 & 3, 2025

USFDA Audit Related Press Release - Cohance

Schedule of Conferences on March 11 & 12, 2025

Schedule of B&K Roadshow on February 28, 2025

Analyst Day on February 27, 2025

Q3FY25_Concall_Transcript

Concall_audio_Q3FY25

Q3FY25_Integrated Filing Financial

Q3FY25_Financial Results

Schedule of Conferences on February14 - 21, 2025

Q3_Revised Schedule of Conference Call for Investors on February 12, 2025

Q3_Schedule of Conference Call for Investors on February 12, 2025

Investor Presentation - January 2025

NJ Bio, Inc. Acquisition - Concall Transcript

Concall Audio_09122024

Acquisition NJ Bio - Schedule of Conference Call for Investors_09122024

Acquisition NJ Bio - Press Release & Investor Presentation

Acquisition NJ Bio - Stock Exchange Intimation

Q2_FY2024_Concall Transcript

Q2_2025_RPT Disclosure.

Q2_FY2024_Concall Audio

Investor Presentation – November 12, 2024

Q2H1 2024 - Financial Results

Q2_Schedule of Conference Call for Investors on November 12, 2024

Schedule of Analyst Meet on September 30, 2024

Press Release - September 19, 2024

Schedule of Analyst Meet on September 18, 2024

FY2024 - Concall Transcript

FY2024 - Concall Audio

Financial Results

Investor Presentation 30th May 2024

Press Release 30th May 2024

RPT Disclosure

FY2024 - Schedule of Concall

Merger_Concall Transcript

Merger_Concall Audio

Merger_Investor Presentation 29th Feb’24

Merger_Press Release 29th Feb’24

Merger_Schedule of Concall on March 05, 2024

Q3_FY2024_Concall_Transcript

Q3_FY2024_Concall Audio

Q3_2023-24_SPL_RESULTS for BM

Q3_2024_Investor_Presentation

Q3_2024_Press_Release

Q2_FY2024_Concall_Transcript

Q2_2024_RPT Disclosure

Q2_2024_Financial_Results

Q2_2024_Investor_Presentation_24th Nov'23

Q2_2024_Investor_Presentation

Q2_2024_Press_Release

Q2_FY2024_Concall_Audio

Q1_2024_Financial_Results

Q1_2024_Investor_Presentation

Q1_FY2024 _Concall_Audio

Q1_FY2024_Concall_Transcript

Subsidiary Financials (Casper Pharma Pvt Ltd) FY 2022-2023

Subsidiary Financials (Casper Pharma Pvt Ltd) FY 2023-2024

Subsidiary Financials (Suven Pharma Inc.) FY 2022-2023

Subsidiary Financials (Suven Pharma Inc.) FY 2023-2024

Business Responsibility and Sustainability Report (BRSR) 2022-2023

Annual Report 2022-2023

Form MGT-7 FY2022-2023

New Release

Financial Results

Investor Presentation

Q1 FY2023 Concall Audio

Q1 Concall Transcript

RPT Disclosure

Financial Results

Investor Presentation

Q2 & HY1 FY2023 - Concall Audio

Q2 & HY1 FY2023 - Concall Audio

Q3 & 9M FY2023 - Earnings Call Transcript

Q3 & 9M FY2023 - Concall Audio

Financial Results

Investor Presentation

Q4 & FY2023 - Earnings Call Transcript

Q4 & FY2023 - Concall Audio

Investor Presentation

Financial Results

RPT Disclosure

New Release

Communication to Investors

Financial Results

Q1 Results - Concall Transcript

New Release

Financial Results

Investor Presentation

Suven Pharmaceuticals Q2 &HY1-FY22 post result Conference call

RPT Disclosure

New Release

Financial Results

Investor Presentation

Suven Pharmaceuticals Q3 &9M-FY22 post result Conference call

Investor Presentation

News Release

Financial Results

Suven Pharmaceuticals - Q4 & F22 concall audio

Suven Pharmaceuticals - Q4 & FY22 concall transcript

RPT Disclosure

Annual Report 2021-2022

Notice of 4th AGM 2022

Business Responsibility Report (BRR) 2021-2022

Form MGT-7 FY2021-2022

Subsidiary Financials (Suven Pharma Inc.) FY 2021-2022

New Release

Communication to Investors

Financial Results

Q1 Results - Concall Transcript

New Release

Communication to Investors

Financial Results

Q2 Results - Concall Transcript

New Release

Communication to Investors

Financial Results

Q3 Results - Concall Transcript

New Release

Communication to Investors

Financial Results

Q4 Results - Concall Transcript

Business Responsibility Report (BRR) 2020-2021​

Annual Report 2020-2021

Notice of 3rd AGM

Form MGT-7 FY2020-2021

Subsidiary Financials (Suven Pharma Inc.) FY 2020-2021

New Release

Communication to Investors

Financial Results

News Release-SPL Release-Q4FY2019-20

Communication to Investors

Financial Results

Cashflow Statement

Earnings Concall transcript

Business Responsibility Report (BRR) 2019-2020

Notice of 2nd AGM

Annual Report 2019 - 2020 flipbook

Annual Report 2019 - 2020

Subsidiary Financials (Suven Pharma Inc.) FY 2019-2020

Q1 FY2025 - Concall Transcript

Q1 2024 - Financial Results

Investor Presentation - 9th August 2024

Press Release - 9th August 2024

Q1FY2025 - Concall Audio for Q1 Financial Results

Schedule of Analyst Meet on September 11, 2024

Schedule of Analyst Meet on September 04, 2024

Schedule of Analyst Meet on August 22, 2024

Q1_Schedule of Conference Call for Investors on August 09, 2024

Investor Presentation 13th June 2024

Schedule of Conference Call for Investors on 19th June 2024

Press Release 13th June 2024

Acquisition - Concall Audio

Acquisition - Concall Transcript

Annual Report 2023-2024

Business Responsibility and Sustainability Report (BRSR) 2023-2024

Form MGT-7 FY2023-2024

Annual Report 2025

Notice of AGM 2025

Business Responsibility and Sustainability Report (BRSR) 2025

Annual Return 2025

ESOP Disclosure - FY2025

Subsidiary Financials FY2025

Health Canada[268]
ANVISA
download
download
FDA
kfda
tfda
OGYEIlogo_2